🔎 Trials Near Me

Utama › Penyakit Paru Interstisial › South Carolina › Charleston

Kajian klinikal Penyakit Paru Interstisial di Charleston, SC

13 kajian untuk Penyakit Paru Interstisial sedang mencari peserta di lokasi dalam dan sekitar Charleston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Mengambil pesertaFasa 3
  • Lowcountry Lung and Critical Care, Charleston
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Mengambil pesertaFasa 3
  • Medical University of South Carolina, Charleston
Umur 40 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07201922

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Mengambil pesertaFasa 2
  • MUSC, Charleston
Umur 18 hingga 80 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05798923

SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers

Mengambil peserta
  • Medical University of South Carolina, Charleston
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07269262

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Mengambil pesertaFasa 2
  • Medical University of South Carolina, Charleston
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06968845

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Mengambil pesertaFasa 2
  • Clinical Research Site, Charleston
Umur 18 hingga 85 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07333183

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Mengambil peserta
  • Medical University of South Carolina, Charleston
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Mengambil pesertaKajian pemerhatian
  • Medical University of South Carolina, Charleston
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

Mengambil pesertaFasa 2
  • Medical University of South Carolina (MUSC), Charleston
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06195072

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Mengambil pesertaKajian pemerhatian
  • Medical University of South Carolina, Charleston
Umur 21 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT01915511

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Mengambil pesertaFasa 3
  • Medical University of South Carolina-Nexus, Charleston
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05943535

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Mengambil pesertaKajian pemerhatian
  • Medical University of South Carolina, Charleston
Umur 18 hingga 80 · Semua jantina · Dikemas kini 26 Jun 2026 · NCT06129240

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Mengambil pesertaFasa 2
  • aTyr Investigative Site, Charleston
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Mei 2025 · NCT05892614

Kajian Penyakit Paru Interstisial di bandar lain

Kajian lain di Charleston

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.